iguratimod has been researched along with citrulline in 1 studies
| Studies (iguratimod) | Trials (iguratimod) | Recent Studies (post-2010) (iguratimod) | Studies (citrulline) | Trials (citrulline) | Recent Studies (post-2010) (citrulline) |
|---|---|---|---|---|---|
| 134 | 19 | 109 | 4,572 | 195 | 1,537 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, L; Li, B; Li, P | 1 |
1 other study(ies) available for iguratimod and citrulline
| Article | Year |
|---|---|
Iguratimod dose dependently inhibits the expression of citrullinated proteins and peptidylarginine deiminases 2 and 4 in neutrophils from rheumatoid arthritis patients.
Topics: Anti-Citrullinated Protein Antibodies; Arthritis, Rheumatoid; Cells, Cultured; Chromones; Citrulline; Cytokines; Female; Humans; Male; Middle Aged; Neutrophils; Peptides, Cyclic; Protein-Arginine Deiminase Type 2; Protein-Arginine Deiminase Type 4; Protein-Arginine Deiminases; Sulfonamides | 2020 |